FEDERATED HERMES, INC. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$542,800
+47.1%
20,000
+66.7%
0.00%0.0%
Q2 2023$368,880
-14.7%
12,0000.0%0.00%0.0%
Q1 2023$432,360
-8.8%
12,0000.0%0.00%0.0%
Q4 2022$474,240
+21.3%
12,000
+53.4%
0.00%0.0%
Q4 2020$391,0007,8220.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders